Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy S Cutler

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Molecules (Basel, Switzerland)|March 10, 2022
<sup>67</sup>Cu Production Capabilities: A Mini ReviewLiliana Mou, Petra Martini, Gaia Pupillo, et al.
Scientific Reports|August 16, 2019
The application of poorly crystalline silicotitanate in production of <sup>225</sup>AcJonathan Fitzsimmons, Alyson Abraham, Demetra Catalano, et al.
Chemical Reviews|December 4, 2012
Radiometals for combined imaging and therapyCathy S Cutler, Heather M Hennkens, Nebiat Sisay, et al.
Nuclear Medicine and Biology|May 29, 2002
Pm-149 DOTA bombesin analogs for potential radiotherapy. in vivo comparison with Sm-153 and Lu-177 labeled DO3A-amide-betaAla-BBN(7-14)NH(2)Fang Hu, Cathy S Cutler, Timothy Hoffman, et al.
Nuclear Medicine and Biology|February 9, 2021
Alpha emitting nuclides for targeted therapyJasmine L Hatcher-Lamarre, Vanessa A Sanders, Mohammed Rahman, et al.
Molecules (Basel, Switzerland)|May 22, 2019
Optimization of Cation Exchange for the Separation of Actinium-225 from Radioactive Thorium, Radium-223 and Other MetalsJonathan Fitzsimmons, Bryan Foley, Bryna Torre, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 23, 2025
Radiopharmaceutical Therapy: Rapid Growth, Rising Challenges, and the Critical Need for ExpertiseHeather A Jacene, Jean-Luc Urbain, Jason S Lewis, et al.
Nuclear Medicine Communications|May 28, 2013
177Lu-labeled RGD-BBN heterodimeric peptide for targeting prostate carcinomaLei Jiang, Zheng Miao, Hongguang Liu, et al.
Nuclear Medicine and Biology|May 7, 2016
Trithiols and their arsenic compounds for potential use in diagnostic and therapeutic radiopharmaceuticalsAnthony J DeGraffenreid, Yutian Feng, Charles L Barnes, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|March 16, 2012
177Lu-DO3A-HSA-Z EGFR:1907: characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomasSusan Hoppmann, Shibo Qi, Zheng Miao, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Molecules (Basel, Switzerland)|March 10, 2022
<sup>67</sup>Cu Production Capabilities: A Mini ReviewLiliana Mou, Petra Martini, Gaia Pupillo, et al.
Scientific Reports|August 16, 2019
The application of poorly crystalline silicotitanate in production of <sup>225</sup>AcJonathan Fitzsimmons, Alyson Abraham, Demetra Catalano, et al.
Chemical Reviews|December 4, 2012
Radiometals for combined imaging and therapyCathy S Cutler, Heather M Hennkens, Nebiat Sisay, et al.
Nuclear Medicine and Biology|May 29, 2002
Pm-149 DOTA bombesin analogs for potential radiotherapy. in vivo comparison with Sm-153 and Lu-177 labeled DO3A-amide-betaAla-BBN(7-14)NH(2)Fang Hu, Cathy S Cutler, Timothy Hoffman, et al.
Nuclear Medicine and Biology|February 9, 2021
Alpha emitting nuclides for targeted therapyJasmine L Hatcher-Lamarre, Vanessa A Sanders, Mohammed Rahman, et al.
Molecules (Basel, Switzerland)|May 22, 2019
Optimization of Cation Exchange for the Separation of Actinium-225 from Radioactive Thorium, Radium-223 and Other MetalsJonathan Fitzsimmons, Bryan Foley, Bryna Torre, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 23, 2025
Radiopharmaceutical Therapy: Rapid Growth, Rising Challenges, and the Critical Need for ExpertiseHeather A Jacene, Jean-Luc Urbain, Jason S Lewis, et al.
Nuclear Medicine Communications|May 28, 2013
177Lu-labeled RGD-BBN heterodimeric peptide for targeting prostate carcinomaLei Jiang, Zheng Miao, Hongguang Liu, et al.
Nuclear Medicine and Biology|May 7, 2016
Trithiols and their arsenic compounds for potential use in diagnostic and therapeutic radiopharmaceuticalsAnthony J DeGraffenreid, Yutian Feng, Charles L Barnes, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|March 16, 2012
177Lu-DO3A-HSA-Z EGFR:1907: characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomasSusan Hoppmann, Shibo Qi, Zheng Miao, et al.
Pageof 7